REBECCA JANEEN WHITE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health BETHESDA, OH NPI 1912470832

General Payments — all program years on this page

$2,804.85

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 163
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $362.82 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $362.8218

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $147.6512
Otsuka America Pharmaceutical, Inc. $121.841
ITI, Inc. $41.532
Indivior Inc. $19.901
ABBVIE INC. $18.091
Janssen Pharmaceuticals, Inc $13.811

By program year

Program yearAmountRecords
2021 $910.0359
2022 $1,022.2859
2023 $509.7227
2024 $362.8218

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078124722 Janssen Pharmaceuticals, Inc $13.81 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108404842 ABBVIE INC. $18.09 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119212989 Otsuka America Pharmaceutical, Inc. $121.84 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143627294 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.12 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143627296 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.41 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144575927 Indivior Inc. $19.90 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647183 Teva Pharmaceuticals USA, Inc. $26.32 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647193 Teva Pharmaceuticals USA, Inc. $19.87 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647233 Teva Pharmaceuticals USA, Inc. $16.14 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647245 Teva Pharmaceuticals USA, Inc. $14.34 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647257 Teva Pharmaceuticals USA, Inc. $12.74 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647259 Teva Pharmaceuticals USA, Inc. $11.29 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647261 Teva Pharmaceuticals USA, Inc. $2.00 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647263 Teva Pharmaceuticals USA, Inc. $5.13 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647265 Teva Pharmaceuticals USA, Inc. $7.68 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647269 Teva Pharmaceuticals USA, Inc. $5.79 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647271 Teva Pharmaceuticals USA, Inc. $13.29 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647273 Teva Pharmaceuticals USA, Inc. $13.06 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.